Faculty profile

Youwen Zhou

ResearcherDermatology and Skin ScienceUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses may be missing. Find their university profile.

Youwen Zhou

Researcher

Dermatology and Skin Science

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
13 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 6 research grants (6 CIHR), most recently in 2022.
Supervisor on 1 trainee award (1 CIHR), most recently in 2015.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Vitiligo Translational Research Gene Knockout Gene Silensing Growth Factors Innate Immunity Macrophages Melanocytes

Latest papers

Immune-Cell Profiling Identifies a Defective Macrophage-Maresin 1 Resolution Axis as a Pathogenic Driver and Therapeutic Target in Vitiligo and Canities.
Journal of cutaneous medicine and surgery · 2026 · senior author
Topical 1.5% ruxolitinib cream for facial refractory segmental vitiligo: A retrospective single-center study.
JAAD international · 2026
Efficacy of ruxolitinib cream at different body sites in Chinese patients with nonsegmental vitiligo.
Journal of the American Academy of Dermatology · 2026

All 61 publications

Latest funding

Efficacy and safety of maresin 1 as a repigmentation therapy for vitiligo
CIHR · 2022 · Nominated PI
$50,000
Role of CLEC12B+ macrophages in the pathogenesis of vitiligo and melanoma
CIHR · 2017 · Nominated PI
$745,875
Characterizing the Genetic Variants for Primary Focal Hyperhidrosis
CIHR · 2015 · Supervisor
$6,000

All 8 grants and awards

61 publications.

Immune-Cell Profiling Identifies a Defective Macrophage-Maresin 1 Resolution Axis as a Pathogenic Driver and Therapeutic Target in Vitiligo and Canities.

Yang Q, Zhang G, Su M, Leung G, Shi Y, Cai A, Ghoreishi M, Sly L, Dutz J, Zhou P, Zhang X, Xu J, Zhou Y

Journal of cutaneous medicine and surgery2026Senior author

DOI: 10.1177/12034754261475634 PMID: 42741921

Topical 1.5% ruxolitinib cream for facial refractory segmental vitiligo: A retrospective single-center study.

Huang H, Duan D, Huang H, Tang X, Zhu C, Zhang Y, Li M, Sheng Y, Xiang L, Cui Y, Zhou Y, Zhang X, Zhang B

JAAD international2026

DOI: 10.1016/j.jdin.2025.08.016 PMID: 41244857

Efficacy of ruxolitinib cream at different body sites in Chinese patients with nonsegmental vitiligo.

Duan D, Zhu C, Gao J, Zhang R, Chen X, Huang H, Zhu Z, Li W, Zhu T, Huang H, Li Y, Liang B, Ding Y, Zhou W, Pan Z, Zhang Y, Xiang L, Zhou Y, Zhang X, Ding Y, Zhang B

Journal of the American Academy of Dermatology2026

DOI: 10.1016/j.jaad.2025.08.117 PMID: 40967308

Unraveling Melasma: From Epidermal Pigmentation to Microenvironmental Dysregulation.

Miao F, Wan J, Zhou Y, Shi Y

Biology2025

DOI: 10.3390/biology14101402 PMID: 41154805

Efficacy and safety of oral upadacitinib-topical ruxolitinib combination therapy in the treatment of progressive nonsegmental vitiligo.

Li W, Gao J, Huang H, Zhu T, Tang X, Zhang R, Chen X, Wang Y, Zhang Y, Zhang X, Cui Y, Zhou Y, Zhang B

JAAD international2025

DOI: 10.1016/j.jdin.2025.04.014 PMID: 40688438

Effectiveness and safety of ruxolitinib cream in Chinese patients with nonsegmental vitiligo.

Huang H, Sheng Y, Li M, Tang X, Zhang Y, Duan D, Huang H, Zhang J, Li W, Zhu T, Tang H, Yin Y, Xiang L, Zhang X, Zhou Y, Cui Y, Zhang B

Journal of the American Academy of Dermatology2025

DOI: 10.1016/j.jaad.2025.04.041 PMID: 40286823

Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus Statement.

Dirr MA, Ahmed A, Schlessinger DI, Haq M, Shi V, Koza E, Ma M, Christensen RE, Ibrahim SA, Schmitt J, Johannsen L, Asai Y, Baldwin HE, Berardesca E, Berman B, Vieira AC, Chien AL, Cohen DE, Del Rosso JQ, Dosal J, Drake LA, Feldman SR, Fleischer AB, Friedman A, Graber E, Harper JC, Helfrich YR, Jemec GB, Johnson SM, Katta R, Lio P, Maier LE, Martin G, Nagler AR, Neuhaus IM, Palamar M, Parish LC, Rosen T, Shumack SP, Solomon JA, Tanghetti EA, Webster GF, Weinkle A, Weiss JS, Wladis EJ, Maher IA, Sobanko JF, Cartee TV, Cahn BA, Alam M, IMPROVED-COS Rosacea Working Group, Kang BY, Iyengar S, Anvery N, Alpsoy E, Bewley A, Dessinioti C, Egeberg A, Engin B, Gollnick HPM, Ioannides D, Kim HS, Lazaridou E, Li J, Lim HG, Micali G, de Oliveira CMM, Noguera-Morel L, Parodi A, Reinholz M, Suh DH, Sun Q, van Zuuren EJ, Wollina U, Zhou Y, Zip C, Poon E, Pearlman R

JAMA dermatology2024

DOI: 10.1001/jamadermatol.2024.0636 PMID: 38656294

Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm.

van Geel N, Speeckaert R, Taïeb A, Ezzedine K, Lim HW, Pandya AG, Passeron T, Wolkerstorfer A, Abdallah M, Alomar A, Bae JM, Bekkenk M, Benzekri L, Böhm M, Eleftheriadou V, Esmat S, Ghia D, Goh BK, Grimes P, Gupta S, Hamzavi IH, Harris JE, Oh SH, Huggins R, Katayama I, Lan E, Lee AY, Leone G, Le Poole C, Lui H, Maquignon N, Meurant JM, Monteiro P, Oiso N, Parsad D, Pliszewski G, Raboobee N, Rodrigues M, Rosmarin D, Suzuki T, Tanemura A, Thng S, Xiang F, Zhou Y, Picardo M, Seneschal J

Journal of the European Academy of Dermatology and Venereology : JEADV2023

DOI: 10.1111/jdv.19451 PMID: 37746876

Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force-Part 2: Specific treatment recommendations.

Seneschal J, Speeckaert R, Taïeb A, Wolkerstorfer A, Passeron T, Pandya AG, Lim HW, Ezzedine K, Zhou Y, Xiang F, Thng S, Tanemura A, Suzuki T, Rosmarin D, Rodrigues M, Raboobee N, Pliszewski G, Parsad D, Oiso N, Monteiro P, Meurant JM, Maquignon N, Lui H, Le Poole C, Leone G, Lee AY, Lan E, Katayama I, Huggins R, Oh SH, Harris JE, Hamzavi IH, Gupta S, Grimes P, Goh BK, Ghia D, Esmat S, Eleftheriadou V, Böhm M, Benzekri L, Bekkenk M, Bae JM, Alomar A, Abdallah M, Picardo M, van Geel N

Journal of the European Academy of Dermatology and Venereology : JEADV2023

DOI: 10.1111/jdv.19450 PMID: 37715487

Vitiligo responds to topical aryl hydrocarbon receptor agonist tapinarof (WBI-1001).

Liu L, Yang Q, Su MW, Zhou Y

JAAD case reports2023Senior author

DOI: 10.1016/j.jdcr.2023.06.051 PMID: 37693929

Efficacy and safety of maresin 1 as a repigmentation therapy for vitiligo

Nominated PICIHR2022Operating Grant: Canadian Dermatology Foundation - Innovation Grants

Principal investigators: Zhou, Youwen

Keywords: Vitiligo

$50,000

Role of CLEC12B+ macrophages in the pathogenesis of vitiligo and melanoma

Nominated PICIHR2017Project Grant

Principal investigators: Zhou, Youwen

Keywords: Gene Knockout; Gene Silensing; Growth Factors; Innate Immunity; Macrophages; Melanocytes; Melanoma; Microenvironment; Monoclonal Antibodies; Vitiligo

$745,875

Characterizing the Genetic Variants for Primary Focal Hyperhidrosis

SupervisorCIHR2015Canada Graduate Scholarships - Michael Smith Foreign Study Supplements

Principal investigators: Huang, Yuanshen

Keywords: Genetic Variants; Hyperhidrosis; Primary Focal Hyperhidrosis

$6,000

Characterising the genetic mutations in familial hyperhidrosis palmaris et plantaris

Nominated PICIHR2013China-Canada Joint Health Research Initiative

Principal investigators: Zhou, Youwen; Yang, Sen

Keywords: Bioinformatitis; Exome Sequencing; Gene Mutations; Hereditary Diseases; Hyperhidrosis; Linkage Analysis; Mental Disorders; Pediatric Morbidity; Sympathetic Nervous System; Translational Research

$225,000

A diagnostic test for cutaneous T cell lymphomas

Nominated PICIHR2012Proof of Principle Program - Phase I

Principal investigators: Zhou, Youwen

Keywords: Cancer Biomarkers; Diagnostic Test; Prognostic Markers; Rabbit Monoclonal Antibody; Skin Lymphomas; Translational Research

$151,660

Abnormal Activation of Thymocytes High-Mobility Group Box Protein (TOX) in Cutaneous T Cell Lymphomas: Pathogenic Significance and Clinical Applications

Nominated PICIHR2011Operating Grant

Principal investigators: Zhou, Youwen

Keywords: Cutaneous T Cell Lymphoma; Epigenomics; Molecular Disease Markers; Sezary Cells; Sezary Syndrome; T Cell Development; Tox

$340,314

Vancouver Pigmentation and Melanoma Research Conference

Nominated PICIHR2010Dissemination Events - PA: Musculoskeletal Hlth, Arthritis, Skin & Oral Health

Principal investigators: Zhou, Youwen

Keywords: Melanoma; Melasma; Pigmentation; Translational Research; Vitiligo

$20,000

Manipulating regulatory T cells to control inflammatory skin disease

Co-investigatorCIHR2008Catalyst Grant: Skin Diseases and Conditions

Principal investigators: Dutz, Jan P

Keywords: Autoimmunity; Dendritic Cell; Flow Cytometry; Regulatory T Cell; Ultraviolet Light

$100,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Youwen Zhou

Research

Latest papers

Latest funding

Immune-Cell Profiling Identifies a Defective Macrophage-Maresin 1 Resolution Axis as a Pathogenic Driver and Therapeutic Target in Vitiligo and Canities.

Topical 1.5% ruxolitinib cream for facial refractory segmental vitiligo: A retrospective single-center study.

Efficacy of ruxolitinib cream at different body sites in Chinese patients with nonsegmental vitiligo.

Unraveling Melasma: From Epidermal Pigmentation to Microenvironmental Dysregulation.

Efficacy and safety of oral upadacitinib-topical ruxolitinib combination therapy in the treatment of progressive nonsegmental vitiligo.

Effectiveness and safety of ruxolitinib cream in Chinese patients with nonsegmental vitiligo.

Rosacea Core Domain Set for Clinical Trials and Practice: A Consensus Statement.

Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm.

Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force-Part 2: Specific treatment recommendations.

Vitiligo responds to topical aryl hydrocarbon receptor agonist tapinarof (WBI-1001).

Frequent collaborators

Harvey Lui

Elena Netchiporouk

Robert Gniadecki

Xiaoyan Jiang

Sunil Kalia

Anie Philip

An-Wen Chan

Sarvesh Logsetty

Elham Rahme

Yuka Asai

Ali Bashashati

Ivan Litvinov

Vincent Piguet

Rachael Manion

Gang Wang

Julie Fradette

Haishan Zeng

Lucie Germain

Laura Sly

Shoukat Dedhar

Artem Cherkasov

Jan Dutz

Morris Manolson

David Huntsman